Market revenue in 2023 | USD 25.8 million |
Market revenue in 2030 | USD 31.6 million |
Growth rate | 2.9% (CAGR from 2023 to 2030) |
Largest segment | Stimulants |
Fastest growing segment | Non-stimulants |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Stimulants, Non-stimulants |
Key market players worldwide | Eli Lilly and Co, Pfizer Inc, Johnson & Johnson, Lupin, Novartis AG ADR, Takeda Pharmaceutical Co Ltd, Mallinckrodt PLC Ordinary Shares - New, Vital KSK Holdings Inc, NeuroSense Therapeutics Ltd, Supernus Pharmaceuticals Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to attention deficit hyperactivity disorder market will help companies and investors design strategic landscapes.
Stimulants was the largest segment with a revenue share of 70.93% in 2023. Horizon Databook has segmented the Kuwait attention deficit hyperactivity disorder market based on stimulants, non-stimulants covering the revenue growth of each sub-segment from 2018 to 2030.
In Kuwait, the ADHD market scenario is shaped by a prevalence that mirrors global trends, affecting a notable percentage of the population, particularly among school-age children. The market is witnessing an increasing awareness of ADHD, leading to greater diagnosis rates and a growing demand for related treatments.
Therapeutic interventions, including both pharmacological and nonpharmacological approaches, play a crucial role in addressing the unique needs of individuals with ADHD in Kuwait. Collaborations between healthcare providers, pharmaceutical entities, and research institutions are driving advancements in ADHD care.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait attention deficit hyperactivity disorder market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait attention deficit hyperactivity disorder market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account